These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 34409999)

  • 1. Severe Acute Respiratory Syndrome Coronavirus 2 Variant Delta Infects All 6 Siblings but Spares Comirnaty (BNT162b2, BioNTech/Pfizer)-Vaccinated Parents.
    Nathan N; Prevost B; Lambert S; Schnuriger A; Corvol H
    J Infect Dis; 2021 Dec; 224(11):1984-1986. PubMed ID: 34409999
    [No Abstract]   [Full Text] [Related]  

  • 2. Status migrainosus: a potential adverse reaction to Comirnaty (BNT162b2, BioNtech/Pfizer) COVID-19 vaccine-a case report.
    Consoli S; Dono F; Evangelista G; D'Apolito M; Travaglini D; Onofrj M; Bonanni L
    Neurol Sci; 2022 Feb; 43(2):767-770. PubMed ID: 34807361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Pfizer/BioNTech and Oxford/AstraZeneca vaccines against COVID-19 morbidity and mortality in real-world settings at countrywide vaccination campaign in Saudi Arabia.
    Meo SA; Fahad Al-Jassir F; Al-Qahtani S; Albarrak R; Usmani AM; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Nov; 25(22):7185-7191. PubMed ID: 34859883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutralisation of the SARS-CoV-2 Delta variant sub-lineages AY.4.2 and B.1.617.2 with the mutation E484K by Comirnaty (BNT162b2 mRNA) vaccine-elicited sera, Denmark, 1 to 26 November 2021.
    Lassaunière R; Polacek C; Fonager J; Bennedbæk M; Boding L; Rasmussen M; Fomsgaard A
    Euro Surveill; 2021 Dec; 26(49):. PubMed ID: 34886943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tachycardia as an undescribed adverse effect to the Comirnaty© vaccine (BNT162b2 Pfizer-BioNTech Covid-19 vaccine): Description of 3 cases with a history of SARS-CoV-2 disease.
    Marco García MT; Torres Lana Á; Anta Agudo MB; Rufino Delgado MT
    Enferm Infecc Microbiol Clin (Engl Ed); 2022 May; 40(5):276-277. PubMed ID: 35484063
    [No Abstract]   [Full Text] [Related]  

  • 6. [Immune thrombocytopenia after BNT162b2 mRNA COVID-19 vaccination].
    Matsumura A; Katsuki K; Akimoto M; Sakuma T; Nakajima Y; Miyazaki T; Fujisawa S; Nakajima H
    Rinsho Ketsueki; 2021; 62(11):1639-1642. PubMed ID: 34866090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
    Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Outbreak in a Long-term Care Facility After Vaccination With BNT162b2.
    Westhölter D; Taube C
    Clin Infect Dis; 2021 Dec; 73(11):2147-2148. PubMed ID: 33825859
    [No Abstract]   [Full Text] [Related]  

  • 9. COVID-19 Therapeutics and Vaccines: A Race to Save Lives.
    Bebenek I; Bannister R; Dubinion J; Fortin M; Liu M; Motter AL; Rohde CM; Wrzesinski C
    Toxicol Sci; 2022 Jan; 185(2):119-127. PubMed ID: 34735018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity of the BNT162b2 COVID-19 mRNA vaccine and early clinical outcomes in patients with haematological malignancies in Lithuania: a national prospective cohort study.
    Maneikis K; Šablauskas K; Ringelevičiūtė U; Vaitekėnaitė V; Čekauskienė R; Kryžauskaitė L; Naumovas D; Banys V; Pečeliūnas V; Beinortas T; Griškevičius L
    Lancet Haematol; 2021 Aug; 8(8):e583-e592. PubMed ID: 34224668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A single dose of the Biontech/Pfizer BNT162b2 vaccine protected elderly residents from severe COVID-19 during a SARS-coronavirus-2 outbreak in a senior citizen home in Germany.
    Schwarzer R; Freys SD; Neuwinger N; Beikert N; Eberspächer B; Edelmann A; Zuchowski M; Slothouwer I; Stein A; Theil K; Menzel P; Hofmann J
    Immun Inflamm Dis; 2021 Dec; 9(4):1809-1814. PubMed ID: 34528766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disseminated herpes zoster in an immune-competent patient after SARS-CoV-2 vaccine (BNT162b2 Comirnaty, Pfizer).
    Zengarini C; Misciali C; Ferrari T; Dika E; La Placa M; Piraccini BM; Baraldi C
    J Eur Acad Dermatol Venereol; 2022 Aug; 36(8):e622-e623. PubMed ID: 35429051
    [No Abstract]   [Full Text] [Related]  

  • 13. Letter comments on: Efficacy and safety of BNT162b2 vaccination in solid cancer patients receiving anti-cancer therapy - A single-centre prospective study: Interaction between lymphopenia and anti-SARS-CoV-2 antibodies after two injections of the Pfizer-BioNTech vaccine in patients with cancers treated by chemotherapy or immunotherapy.
    Sekkate S; Stoeklé HC; Mabro M; Billard D; Kennel T; Vasse M; Hervé C; Beuzeboc P
    Eur J Cancer; 2022 Jan; 160():282-284. PubMed ID: 34810045
    [No Abstract]   [Full Text] [Related]  

  • 14. Effectiveness of BNT162b2 Vaccine against Delta Variant in Adolescents.
    Reis BY; Barda N; Leshchinsky M; Kepten E; Hernán MA; Lipsitch M; Dagan N; Balicer RD
    N Engl J Med; 2021 Nov; 385(22):2101-2103. PubMed ID: 34670036
    [No Abstract]   [Full Text] [Related]  

  • 15. Editorial: First Full Regulatory Approval of a COVID-19 Vaccine, the BNT162b2 Pfizer-BioNTech Vaccine, and the Real-World Implications for Public Health Policy.
    Parums DV
    Med Sci Monit; 2021 Sep; 27():e934625. PubMed ID: 34483336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Detection of antibodies against SARS-CoV-2 in CHUAC emergency staff after the administration of the Comirnaty vaccine (Pfizer-BioNTech): a retrospective study].
    Rodríguez Buyo IM; González Vázquez A; Rey Paraños I; Seijas González A
    Aten Primaria; 2023 Aug; 55(8):102675. PubMed ID: 37247534
    [No Abstract]   [Full Text] [Related]  

  • 17. Perimyocarditis in Adolescents After Pfizer-BioNTech COVID-19 Vaccine.
    Tano E; San Martin S; Girgis S; Martinez-Fernandez Y; Sanchez Vegas C
    J Pediatric Infect Dis Soc; 2021 Nov; 10(10):962-966. PubMed ID: 34319393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-term outcome of pregnant women vaccinated with BNT162b2 mRNA COVID-19 vaccine.
    Bookstein Peretz S; Regev N; Novick L; Nachshol M; Goffer E; Ben-David A; Asraf K; Doolman R; Levin EG; Regev Yochay G; Yinon Y
    Ultrasound Obstet Gynecol; 2021 Sep; 58(3):450-456. PubMed ID: 34198360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of Pfizer-BioNTech and Moderna Vaccines in Preventing SARS-CoV-2 Infection Among Nursing Home Residents Before and During Widespread Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant - National Healthcare Safety Network, March 1-August 1, 2021.
    Nanduri S; Pilishvili T; Derado G; Soe MM; Dollard P; Wu H; Li Q; Bagchi S; Dubendris H; Link-Gelles R; Jernigan JA; Budnitz D; Bell J; Benin A; Shang N; Edwards JR; Verani JR; Schrag SJ
    MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(34):1163-1166. PubMed ID: 34437519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pfizer-BioNTech mRNA BNT162b2 Covid-19 vaccine protection against variants of concern after one versus two doses.
    Abu-Raddad LJ; Chemaitelly H; Yassine HM; Benslimane FM; Al Khatib HA; Tang P; Malek JA; Coyle P; Ayoub HH; Al Kanaani Z; Al Kuwari E; Jeremijenko A; Kaleeckal AH; Latif AN; Shaik RM; Abdul Rahim HF; Nasrallah GK; Al Kuwari MG; Al Romaihi HE; Al-Thani MH; Al Khal A; Butt AA; Bertollini R
    J Travel Med; 2021 Oct; 28(7):. PubMed ID: 34050372
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.